Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
ClinicalTrials.gov study NCT05286528. IPD Sharing: NO. Countries: 1. Publications: 0.
ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT04216563. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TIGIT in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04818619. IPD Sharing: Not stated. Countries: 0. Publications: 8.
Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure
ClinicalTrials.gov study NCT02906696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02011945. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
ClinicalTrials.gov study NCT01428635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT01872442. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase
ClinicalTrials.gov study NCT07383298. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
ClinicalTrials.gov study NCT01660906. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
ClinicalTrials.gov study NCT01795716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03399773. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00482703. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
ClinicalTrials.gov study NCT01083706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04925479. IPD Sharing: YES. Countries: 14. Publications: 0.
Myeloid Derived Suppressor Cells and Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03214718. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib
ClinicalTrials.gov study NCT00320190. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00573378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
ClinicalTrials.gov study NCT01169753. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02078960. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously T
ClinicalTrials.gov study NCT03146871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.